Article | June 6, 2022

Decentralized Clinical Trials Represent The Decentralization Of Care: What That Means For Patients

Source: Medable
GettyImages-1286810741 patient computer

Nothing has accelerated the adoption of decentralized care like the COVID-19 pandemic. Suddenly, it seemed everyone was using video calls in place of in-person appointments — and liking it. In fact, use of telehealth skyrocketed by 50 percent in the first quarter of 2020 compared with the same period in 2019, according to the Centers for Disease Control, and it now accounts for 17 percent of all outpatient visits. In a January 2021 survey, about 40 percent of people said they expect to continue using telehealth after the pandemic ends.

This transformation of service delivery didn’t occur just in direct patient care, however. At the beginning of the pandemic, thousands of clinical trials were suspended for the safety of investigators and participants alike. Soon, however, the FDA issued guidance for conducting trials virtually, and the industry enthusiastically embraced them as their benefits became immediately apparent.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader